Novo Nordisk (NOVO) AGM 2019 summary

Financial performance review

• Statutory Annual Report 2018 approved.

Board and executive committee updates

• Helge Lund and Jeppe Christiansen re-elected as chair and vice chair; Brian Daniels, Andreas Fibig, Sylvie Grégoire, Liz Hewitt, Kasim Kutay and Martin Mackay re-elected as directors.

• Laurence Debroux elected as a new director; PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab reappointed as auditor.

• Committee appointments included Helge Lund as Nomination Committee chair, Jeppe Christiansen as Remuneration Committee chair, Liz Hewitt as Audit Committee chair and Martin Mackay as R&D Committee chair.

Shareholder proposals

• Proposal to reduce prices if return on equity exceeded 7% was rejected.